Figure 3.
Steady-state serum concentration-time profiles of tolterodine in the absence (a) and presence (b) of ketoconazole, 200 mg once daily, after 1 mg twice-daily administration of tolterodine l-tartrate to subjects with deficient CYP2D6 activity.